Proper functioning of the respiratory system is one of the most important determinants of human health. According to current knowledge, the diaphragmatic breathing pattern seems to be the most ...

Pulmonary function tests (PFTs) measures such as forced expiratory volume in 1 s (FEV 1), forced vital capacity (FVC), and diffusing capacity for carbon monoxide (DLCO) are reported in the context of ...

A structured pediatric pulmonary rehabilitation (PR) program improved 6-minute walking test distance by approximately 230 feet and significantly enhanced strength and agility metrics. Spirometric ...

Researchers review pulmonary function testing measures that span 4 categories that can assess the respiratory muscle dysfunction that happens in diseases like spinal muscular atrophy (SMA). Muscle ...

Please provide your email address to receive an email when new articles are posted on . A smartphone-based tool that employs acoustic sensing and machine learning techniques is set to undergo testing.

The Social Security Administration has requested the National Academies of Sciences, Engineering, and Medicine to review the latest published research and science and produce a report addressing best ...

Out of 109 participants, 48 received early treatment, accounting for 44% of the trial population.

A phlegmy cough and shortness of breath are possible warning signs of chronic obstructive pulmonary disease (COPD). Keeping track of your symptoms and knowing your risk factors can help you test ...

Pulmonary hypertension is characterized by increased BP in the pulmonary vasculature You will want your patients to consult a specialist to slow progression of this debilitating disease. Here's what ...

Cor pulmonale is a condition that affects the right ventricle in the heart, altering its structure and proper functioning. It is caused by a respiratory system disorder. Pulmonary hypertension is a ...

One of the first areas affected by smoking is the respiratory tract. Smoking damages and weakens these protective structures.

SAINT PAUL, Minn.--(BUSINESS WIRE)--Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the first patient was implanted with the Gen 2 Aria CV Pulmonary ...